162 related articles for article (PubMed ID: 28684242)
21. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic body radiation therapy for bone oligometastases.
Naessens C; Chamois J; Supiot S; Faivre JC; Arnaud A; Thureau S
Cancer Radiother; 2024 Feb; 28(1):111-118. PubMed ID: 37838605
[TBL] [Abstract][Full Text] [Related]
23. New Strategies in Stereotactic Radiotherapy for Oligometastases.
Palma DA; Louie AV; Rodrigues GB
Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
[TBL] [Abstract][Full Text] [Related]
24. Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors.
Stumpf PK; Yorke ED; El Naqa I; Cuneo KC; Grimm J; Goodman KA
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):217-226. PubMed ID: 33864824
[TBL] [Abstract][Full Text] [Related]
25. Review and uses of stereotactic body radiation therapy for oligometastases.
Alongi F; Arcangeli S; Filippi AR; Ricardi U; Scorsetti M
Oncologist; 2012; 17(8):1100-7. PubMed ID: 22723509
[TBL] [Abstract][Full Text] [Related]
26. [Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].
Keller A; Doré M; Antoni D; Menoux I; Thillays F; Clavier JB; Delpon G; Jarnet D; Bourrier C; Lefebvre F; Chibbaro S; Darié I; Proust F; Noël G
Cancer Radiother; 2017 Aug; 21(5):377-388. PubMed ID: 28551018
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiotherapy for adrenal gland metastases: university of Florence experience.
Casamassima F; Livi L; Masciullo S; Menichelli C; Masi L; Meattini I; Bonucci I; Agresti B; Simontacchi G; Doro R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):919-23. PubMed ID: 21300473
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model.
Diletto B; Dinapoli N; Chiesa S; Mattiucci GC; Frascino V; Anile C; Colosimo C; Valentini V; Balducci M
Med Oncol; 2018 Sep; 35(11):146. PubMed ID: 30218407
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiotherapy for large solitary brain metastases.
Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
[TBL] [Abstract][Full Text] [Related]
30. [Stereotactic body radiation therapy for spinal metastases].
Pasquier D; Martinage G; Mirabel X; Lacornerie T; Makhloufi S; Faivre JC; Thureau S; Lartigau É
Cancer Radiother; 2016 Oct; 20(6-7):500-7. PubMed ID: 27614511
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases.
Bignardi M; Navarria P; Mancosu P; Cozzi L; Fogliata A; Tozzi A; Castiglioni S; Carnaghi C; Tronconi MC; Santoro A; Scorsetti M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):831-8. PubMed ID: 20800375
[TBL] [Abstract][Full Text] [Related]
32. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
33. Long-term control of melanoma adrenal metastasis treated with radiotherapy.
McCann B; Higgins M; Kok DL; Hong W; Alipour R; Chua MST
Melanoma Res; 2022 Jun; 32(3):166-172. PubMed ID: 35256569
[TBL] [Abstract][Full Text] [Related]
34. The role of stereotactic radiotherapy in the treatment of oligometastases.
Videtic GM
Curr Oncol Rep; 2014 Jul; 16(7):391. PubMed ID: 24861005
[TBL] [Abstract][Full Text] [Related]
35. [Radiotherapy for patients with early-stage glottic squamous cell carcinoma of the larynx: Interest of hypofractionation?].
Tonneau M; Matta R; Lals S; Mirabel X; Crop F; Lacornerie T; Pasquier D; Escande A; Liem X
Cancer Radiother; 2021 Dec; 25(8):801-810. PubMed ID: 33931299
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiation therapy for curative treatment of adrenal metastases.
Rudra S; Malik R; Ranck MC; Farrey K; Golden DW; Hasselle MD; Weichselbaum RR; Salama JK
Technol Cancer Res Treat; 2013 Jun; 12(3):217-24. PubMed ID: 23369155
[TBL] [Abstract][Full Text] [Related]
37. [Delineation of organs at risk and dose constraints].
Noël G; Antoni D; Barillot I; Chauvet B
Cancer Radiother; 2016 Sep; 20 Suppl():S36-60. PubMed ID: 27516050
[TBL] [Abstract][Full Text] [Related]
38. Physics and imaging for targeting of oligometastases.
Yin FF; Das S; Kirkpatrick J; Oldham M; Wang Z; Zhou SM
Semin Radiat Oncol; 2006 Apr; 16(2):85-101. PubMed ID: 16564444
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.
Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N
World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
